INDIVIOR PHARMACEUTICALS INC (INDV) Fundamental Analysis & Valuation

NASDAQ:INDV • US45579U1097

Current stock price

34.43 USD
+0.12 (+0.35%)
At close:
34.43 USD
0 (0%)
After Hours:

This INDV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. INDV Profitability Analysis

1.1 Basic Checks

  • In the past year INDV was profitable.
  • INDV had a positive operating cash flow in the past year.
  • In multiple years INDV reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
INDV Yearly Net Income VS EBIT VS OCF VS FCFINDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With an excellent Return On Assets value of 8.62%, INDV belongs to the best of the industry, outperforming 89.01% of the companies in the same industry.
  • INDV has a better Return On Invested Capital (50.62%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 13.10%.
  • The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.62%
ROE N/A
ROIC 50.62%
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
INDV Yearly ROA, ROE, ROICINDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300 400

1.3 Margins

  • INDV's Profit Margin of 10.34% is amongst the best of the industry. INDV outperforms 85.34% of its industry peers.
  • INDV's Profit Margin has declined in the last couple of years.
  • INDV has a Operating Margin of 24.49%. This is amongst the best in the industry. INDV outperforms 92.67% of its industry peers.
  • In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
  • INDV has a better Gross Margin (85.51%) than 89.53% of its industry peers.
  • INDV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.49%
PM (TTM) 10.34%
GM 85.51%
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
INDV Yearly Profit, Operating, Gross MarginsINDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. INDV Health Analysis

2.1 Basic Checks

  • INDV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • INDV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INDV Yearly Shares OutstandingINDV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
INDV Yearly Total Debt VS Total AssetsINDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.67 indicates that INDV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • INDV has a better Altman-Z score (2.67) than 63.87% of its industry peers.
  • The Debt to FCF ratio of INDV is 2.68, which is a good value as it means it would take INDV, 2.68 years of fcf income to pay off all of its debts.
  • INDV has a Debt to FCF ratio of 2.68. This is amongst the best in the industry. INDV outperforms 92.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.68
Altman-Z 2.67
ROIC/WACC5.16
WACC9.82%
INDV Yearly LT Debt VS Equity VS FCFINDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • INDV has a Current Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.96, INDV is not doing good in the industry: 87.96% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.79 indicates that INDV may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.79, INDV is not doing good in the industry: 85.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.79
INDV Yearly Current Assets VS Current LiabilitesINDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. INDV Growth Analysis

3.1 Past

  • INDV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 459.09%, which is quite impressive.
EPS 1Y (TTM)459.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.13%

3.2 Future

  • INDV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.40% yearly.
  • The Revenue is expected to grow by 2.98% on average over the next years.
EPS Next Y27.98%
EPS Next 2Y19.17%
EPS Next 3Y16.42%
EPS Next 5Y9.4%
Revenue Next Year-2.63%
Revenue Next 2Y1.23%
Revenue Next 3Y3.01%
Revenue Next 5Y2.98%

3.3 Evolution

INDV Yearly Revenue VS EstimatesINDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
INDV Yearly EPS VS EstimatesINDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. INDV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.00, which indicates a correct valuation of INDV.
  • 87.43% of the companies in the same industry are more expensive than INDV, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of INDV to the average of the S&P500 Index (26.91), we can say INDV is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 10.94, the valuation of INDV can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, INDV is valued cheaper than 86.91% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. INDV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14
Fwd PE 10.94
INDV Price Earnings VS Forward Price EarningsINDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INDV is valued cheaply inside the industry as 83.77% of the companies are valued more expensively.
  • INDV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INDV is cheaper than 81.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.98
EV/EBITDA 12.89
INDV Per share dataINDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INDV may justify a higher PE ratio.
  • INDV's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y19.17%
EPS Next 3Y16.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INDV Dividend Analysis

5.1 Amount

  • No dividends for INDV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INDV Fundamentals: All Metrics, Ratios and Statistics

INDIVIOR PHARMACEUTICALS INC

NASDAQ:INDV (4/28/2026, 4:30:03 PM)

After market: 34.43 0 (0%)

34.43

+0.12 (+0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners90.94%
Inst Owner Change0.34%
Ins Owners3.95%
Ins Owner Change39.75%
Market Cap4.20B
Revenue(TTM)N/A
Net Income(TTM)122.00M
Analysts84.62
Price Target47.79 (38.8%)
Short Float %11.93%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)4
Avg EPS beat(4)70.49%
Min EPS beat(4)45.92%
Max EPS beat(4)92.31%
EPS beat(8)6
Avg EPS beat(8)12.14%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)4
Avg Revenue beat(4)14.97%
Min Revenue beat(4)8.6%
Max Revenue beat(4)21.1%
Revenue beat(8)5
Avg Revenue beat(8)7.48%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.82%
PT rev (3m)9.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14
Fwd PE 10.94
P/S 3.56
P/FCF 34.98
P/OCF 23.32
P/B N/A
P/tB N/A
EV/EBITDA 12.89
EPS(TTM)2.46
EY7.14%
EPS(NY)3.15
Fwd EY9.14%
FCF(TTM)0.98
FCFY2.86%
OCF(TTM)1.48
OCFY4.29%
SpS9.68
BVpS-1.7
TBVpS-1.71
PEG (NY)0.5
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 8.62%
ROE N/A
ROCE 64.08%
ROIC 50.62%
ROICexc 3805.17%
ROICexgc 5707.75%
OM 24.49%
PM (TTM) 10.34%
GM 85.51%
FCFM 10.17%
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.68
Debt/EBITDA 0.97
Cap/Depr 230.77%
Cap/Sales 5.08%
Interest Coverage 250
Cash Conversion 57.14%
Profit Quality 98.36%
Current Ratio 0.96
Quick Ratio 0.79
Altman-Z 2.67
F-Score8
WACC9.82%
ROIC/WACC5.16
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)459.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156.25%
EPS Next Y27.98%
EPS Next 2Y19.17%
EPS Next 3Y16.42%
EPS Next 5Y9.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.13%
Revenue Next Year-2.63%
Revenue Next 2Y1.23%
Revenue Next 3Y3.01%
Revenue Next 5Y2.98%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1051.87%
EBIT Next 3Y149.29%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%

INDIVIOR PHARMACEUTICALS INC / INDV Fundamental Analysis FAQ

What is the fundamental rating for INDV stock?

ChartMill assigns a fundamental rating of 5 / 10 to INDV.


What is the valuation status for INDV stock?

ChartMill assigns a valuation rating of 8 / 10 to INDIVIOR PHARMACEUTICALS INC (INDV). This can be considered as Undervalued.


How profitable is INDIVIOR PHARMACEUTICALS INC (INDV) stock?

INDIVIOR PHARMACEUTICALS INC (INDV) has a profitability rating of 7 / 10.


Can you provide the financial health for INDV stock?

The financial health rating of INDIVIOR PHARMACEUTICALS INC (INDV) is 4 / 10.


What is the expected EPS growth for INDIVIOR PHARMACEUTICALS INC (INDV) stock?

The Earnings per Share (EPS) of INDIVIOR PHARMACEUTICALS INC (INDV) is expected to grow by 27.98% in the next year.